HROW vs. HALO
Compare and contrast key facts about Harrow Health, Inc. (HROW) and Halozyme Therapeutics, Inc. (HALO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HROW or HALO.
Correlation
The correlation between HROW and HALO is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HROW vs. HALO - Performance Comparison
Key characteristics
HROW:
2.76
HALO:
1.47
HROW:
4.04
HALO:
2.02
HROW:
1.49
HALO:
1.31
HROW:
2.55
HALO:
1.37
HROW:
13.42
HALO:
4.83
HROW:
17.72%
HALO:
12.28%
HROW:
86.61%
HALO:
40.61%
HROW:
-99.46%
HALO:
-74.26%
HROW:
-76.60%
HALO:
-13.29%
Fundamentals
HROW:
$1.15B
HALO:
$7.11B
HROW:
-$0.95
HALO:
$3.02
HROW:
$132.78M
HALO:
$717.32M
HROW:
$97.67M
HALO:
$564.43M
HROW:
$2.55M
HALO:
$443.38M
Returns By Period
In the year-to-date period, HROW achieves a -3.76% return, which is significantly lower than HALO's 16.84% return. Over the past 10 years, HROW has outperformed HALO with an annualized return of 15.98%, while HALO has yielded a comparatively lower 14.66% annualized return.
HROW
-3.76%
-3.61%
33.54%
232.54%
37.51%
15.98%
HALO
16.84%
16.06%
0.70%
63.29%
23.53%
14.66%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HROW vs. HALO — Risk-Adjusted Performance Rank
HROW
HALO
HROW vs. HALO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HROW vs. HALO - Dividend Comparison
Neither HROW nor HALO has paid dividends to shareholders.
Drawdowns
HROW vs. HALO - Drawdown Comparison
The maximum HROW drawdown since its inception was -99.46%, which is greater than HALO's maximum drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for HROW and HALO. For additional features, visit the drawdowns tool.
Volatility
HROW vs. HALO - Volatility Comparison
Harrow Health, Inc. (HROW) has a higher volatility of 17.58% compared to Halozyme Therapeutics, Inc. (HALO) at 8.42%. This indicates that HROW's price experiences larger fluctuations and is considered to be riskier than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HROW vs. HALO - Financials Comparison
This section allows you to compare key financial metrics between Harrow Health, Inc. and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities